Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematological Patients”

532 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 532 results

Not applicableActive Not RecruitingNCT05236764
What this trial is testing

Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion

Who this might be right for
Acute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in RemissionMyelodysplastic Syndromes+8 more
Baylor College of Medicine 3
Not applicableStudy completedNCT01519648
What this trial is testing

A Russian Prospective Observational Study of Invasive Fungal Infections in Patients With Acute Leukemia and Hematopoietic Stem Cell Transplantation

Who this might be right for
Invasive Fungal Infections
National Hematological Society, Russia 808
Testing effectiveness (Phase 2)Study completedNCT00914849
What this trial is testing

Intravenous (IV) AMD3100 for Mobilization and Matched Related Transplant for Advanced Hematological Malignancies

Who this might be right for
Hematologic Neoplasms
Washington University School of Medicine 68
Testing effectiveness (Phase 2)Looking for participantsNCT05768035
What this trial is testing

Safety and Efficacy of SMART101 in Adult Patients With Hematological Malignancies After Haploidentical HSCT With Post-transplant Cyclophosphamide

Who this might be right for
Hematological Malignancies
Smart Immune SAS 40
Not applicableStudy completedNCT02841124
What this trial is testing

Decision to Limit or Withdraw Specific Therapies for Advanced Cancer and Hematological Malignancies.

Who this might be right for
Advanced CancerEthics
Centre Hospitalier Universitaire de Besancon 21
Not applicableStudy completedNCT06806124
What this trial is testing

Impact of the Elevation Training Mask in CrossFit® Post-SARS-CoV-2 Infection.

Who this might be right for
COVID19- Infection with SARS-CoV-2 VirusSARS-CoV-2 Positive PatientsCOVID-19 Pulmonary Complications+1 more
University of Valladolid 20
Very early researchLooking for participantsNCT04532203
What this trial is testing

CAR-T Cells Therapy for Patients With Relapsed and/or Refractory Central Nervous System Hematological Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaNon-Hodgkin's Lymphoma
Zhejiang University 72
Very early researchLooking for participantsNCT04603872
What this trial is testing

CAR-T Cells Combined With Dasatinib for Patients With Relapsed and/or Refractory B-cell Hematological Malignancies

Who this might be right for
Multiple Myeloma in RelapseMultiple Myeloma, RefractoryAcute Lymphoblastic Leukemia, in Relapse+3 more
Zhejiang University 120
Testing effectiveness (Phase 2)Study completedNCT00721734
What this trial is testing

Study of the Safety and Pharmacokinetics of Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function

Who this might be right for
Multiple MyelomaRenal Insufficiency
Amgen 50
Not applicableStudy completedNCT01758484
What this trial is testing

Supportive Care for Patients With Hematological Malignancies Undergoing Hematopoietic Cell Transplant

Who this might be right for
Hematopoietic/Lymphoid Cancer
Fred Hutchinson Cancer Center 20
Not applicableStudy completedNCT07235436
What this trial is testing

Platelet Cryopreservation

Who this might be right for
Platelet Cryopreservation
Azienda USL Reggio Emilia - IRCCS 10
Testing effectiveness (Phase 2)Study completedNCT01315132
What this trial is testing

Bone Marrow Transplantation Using Fully-Matched Relatives as Donors for Patients With Hematological Malignancies

Who this might be right for
Hematological MalignanciesLeukemiaLymphoma+2 more
Sidney Kimmel Cancer Center at Thomas Jefferson University 47
Testing effectiveness (Phase 2)Study completedNCT03159845
What this trial is testing

Zinc as Enhancer in Immune Recovery After Stem Cell Transplantation for Hematological Malignancies

Who this might be right for
Stem Cell Transplant Complications
Azienda Ospedaliero, Universitaria Pisana 20
Not applicableUnknownNCT05001386
What this trial is testing

In Vitro Drug Sensitivity Testing of Fresh Human Samples

Who this might be right for
Myeloproliferative DisordersLymphoproliferative Disorders
Hospices Civils de Lyon 800
Early research (Phase 1)Ended earlyNCT00963495
What this trial is testing

Study Evaluating the Tolerance and Biological Activity of Oral Clioquinol in Patients With Relapsed or Refractory Hematological Malignancy

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphocytic LeukemiaChronic Lymphocytic Leukemia+4 more
University Health Network, Toronto 11
Early research (Phase 1)Looking for participantsNCT06049667
What this trial is testing

Clinical Trail of NTQ2494 Tablets in Patients With Advanced Hematological Malignancies

Who this might be right for
Relapsed/Refractory Acute Myeloid Leukemia (AML)
Nanjing Chia-tai Tianqing Pharmaceutical 72
Testing effectiveness (Phase 2)Ended earlyNCT04735575
What this trial is testing

A Ph1/2 Study of EMB-06 in Participants With Relapsed or Refractory Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Shanghai EpimAb Biotherapeutics Co., Ltd. 40
Post-approval studies (Phase 4)Study completedNCT02149329
What this trial is testing

Short Versus Extended Antibiotic Treatment With a Carbapenem for High-risk Febrile Neutropenia in Hematology Patients With FUO

Who this might be right for
Febrile NeutropeniaHematological Malignancy
Amsterdam UMC, location VUmc 276
Testing effectiveness (Phase 2)Study completedNCT00040846
What this trial is testing

Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+97 more
Fred Hutchinson Cancer Center 60
Not applicableStudy completedNCT00179764
What this trial is testing

Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC])

Who this might be right for
TumorsMalignant MelanomaHematological Malignancies+2 more
Ann & Robert H Lurie Children's Hospital of Chicago 68
Load More Results